Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial
Julian Gold, Dominic B. Rowe, Matthew C. Kiernan, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2019) Vol. 20, Iss. 7-8, pp. 595-604
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Improving clinical trial outcomes in amyotrophic lateral sclerosis
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, et al.
Nature Reviews Neurology (2020) Vol. 17, Iss. 2, pp. 104-118
Open Access | Times Cited: 226
Resurrection of endogenous retroviruses during aging reinforces senescence
Xiaoqian Liu, Zunpeng Liu, Zeming Wu, et al.
Cell (2023) Vol. 186, Iss. 2, pp. 287-304.e26
Open Access | Times Cited: 210
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Disease-modifying therapies in amyotrophic lateral sclerosis
Adriano Chiò, Letizia Mazzini, Gabriele Mora
Neuropharmacology (2020) Vol. 167, pp. 107986-107986
Closed Access | Times Cited: 97
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
Elisabetta Zucchi, Valentina Bonetto, Gianni Sorarù, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 83
Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis
Belgin Sever, Halil I. Ciftci, Hasan DeMi̇rci̇, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2400-2400
Open Access | Times Cited: 50
Endogenous retroviruses in development and health
Jichang Wang, Xinyi Lu, Weiqi Zhang, et al.
Trends in Microbiology (2023) Vol. 32, Iss. 4, pp. 342-354
Closed Access | Times Cited: 32
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines
Valentina Zanrè, Francesco Bellinato, Alessia Cardile, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1615-1615
Open Access | Times Cited: 10
TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression
Marta García‐Montojo, Saeed Fathi, Cyrus Rastegar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson's Disease
Yuhong Fu, Gabrielle L. Adler, Priscilla Youssef, et al.
Movement Disorders (2025)
Open Access | Times Cited: 1
Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis
Guoying Wang, Stephanie L. Rayner, Roger S. Chung, et al.
Materials Today Bio (2020) Vol. 6, pp. 100055-100055
Open Access | Times Cited: 63
Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous system
Paulino Ramirez, Gabrielle Zuniga, Wenyan Sun, et al.
Progress in Neurobiology (2021) Vol. 208, pp. 102181-102181
Open Access | Times Cited: 55
Transposable elements as new players in neurodegenerative diseases
Camille Ravel‐Godreuil, Rania Znaidi, Tom Bonnifet, et al.
FEBS Letters (2021) Vol. 595, Iss. 22, pp. 2733-2755
Open Access | Times Cited: 41
Retrotransposons as a Source of DNA Damage in Neurodegeneration
Eugénie Pezé-Heidsieck, Tom Bonnifet, Rania Znaidi, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 29
Human Endogenous Retroviruses in Neurodegenerative Diseases
Gabrielle L. Adler, Kelvin Le, Yuhong Fu, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 745-745
Open Access | Times Cited: 7
Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis
Chris Ugbode, Ryan J. H. West
Neurobiology of Disease (2020) Vol. 147, pp. 105144-105144
Open Access | Times Cited: 40
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy
Marta García‐Montojo, Saeed Fathi, Gina Norato, et al.
Journal of the Neurological Sciences (2021) Vol. 423, pp. 117358-117358
Open Access | Times Cited: 39
Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic
Joseph P. Steiner, Muzna Bachani, Nasir Malik, et al.
Annals of Neurology (2022) Vol. 92, Iss. 4, pp. 545-561
Open Access | Times Cited: 28
A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer’s disease (ART-AD)
A. Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications
Aicee Dawn Calma, Nathan Pavey, Parvathi Menon, et al.
Current Opinion in Neurology (2024) Vol. 37, Iss. 5, pp. 585-592
Closed Access | Times Cited: 5
Endogenous Retroviruses in Nervous System Disorders
Victoria Gröger, Alexander Emmer, Martin S. Staege, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 1, pp. 70-70
Open Access | Times Cited: 29
The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy
Megan Dubowsky, Frances Theunissen, Jillian M. Carr, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6330-6345
Open Access | Times Cited: 11
Role of Retroelements in Frontotemporal Dementia Development
Р. Н. Мустафин
Frontiers in Bioscience-Scholar (2025) Vol. 17, Iss. 1
Open Access
Drug Combination to Slow Down the Progression of Amyotrophic Lateral Sclerosis
Myriam Torres-Rico, Borja Marín-Rodríguez, Miriam Samira Arasmou-Idrovo, et al.
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
Human Endogenous Retroviruses as Novel Therapeutic Targets in Neurodegenerative Disorders
Elena Rita Simula, Seyedesomaye Jasemi, Davide Cossu, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 415-415
Open Access
Page 1 - Next Page

Scroll to top